Citadel Advisors’s Diebold Nixdorf Incorporated DBD Stock Holding History

Citadel Advisors’s Portfolio DBD Stock Details DBD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-105,900	Closed	-$127K	–	15673
2023 Q1	$127K	Buy	105,900 +74,900	+242%	+$167K	﹤0.01%	10902
2022 Q4	$44K	Sell	31,000 -93,600	-75%	-$201K	﹤0.01%	12284
2022 Q3	$304K	Buy	124,600 +101,900	+449%	+$340K	﹤0.01%	9559
2022 Q2	$52K	Buy	22,700 +800	+4%	+$2.98K	﹤0.01%	11927
2022 Q1	$147K	Sell	21,900 -126,400	-85%	-$1.08M	﹤0.01%	11875
2021 Q4	$1.34M	Sell	148,300 -23,000	-13%	-$214K	﹤0.01%	7160
2021 Q3	$1.73M	Sell	171,300 -52,800	-24%	-$579K	﹤0.01%	6732
2021 Q2	$2.88M	Sell	224,100 -64,700	-22%	-$887K	﹤0.01%	5702
2021 Q1	$4.08M	Sell	288,800 -21,300	-7%	-$293K	﹤0.01%	4716
2020 Q4	$3.31M	Sell	310,100 -2,000	-0.6%	-$18.2K	﹤0.01%	4415
2020 Q3	$2.38M	Sell	312,100 -4,700	-1%	-$34.6K	﹤0.01%	4406
2020 Q2	$1.92M	Sell	316,800 -6,400	-2%	-$31.6K	﹤0.01%	4656
2020 Q1	$1.14M	Sell	323,200 -74,100	-19%	-$628K	﹤0.01%	5099
2019 Q4	$4.2M	Buy	397,300 +193,000	+94%	+$1.71M	﹤0.01%	3295
2019 Q3	$2.29M	Buy	204,300 +85,800	+72%	+$1.02M	﹤0.01%	4262
2019 Q2	$1.08M	Buy	118,500 +68,300	+136%	+$713K	﹤0.01%	5569
2019 Q1	$556K	Buy	+50,200	New	+$351K	﹤0.01%	6622
2018 Q4	–	Sell	-106,700	Closed	-$480K	–	9958
2018 Q3	$480K	Buy	106,700 +63,600	+148%	+$464K	﹤0.01%	6764
2018 Q2	$515K	Sell	43,100 -18,100	-30%	-$242K	﹤0.01%	6318
2018 Q1	$942K	Buy	61,200 +8,400	+16%	+$140K	﹤0.01%	4909
2017 Q4	$863K	Buy	52,800 +34,900	+195%	+$675K	﹤0.01%	4866
2017 Q3	$409K	Buy	+17,900	New	+$381K	﹤0.01%	5602
2017 Q2	–	Sell	-7,700	Closed	-$236K	–	8248
2017 Q1	$236K	Sell	7,700 -22,500	-75%	-$635K	﹤0.01%	6260
2016 Q4	$760K	Sell	30,200 -7,100	-19%	-$167K	﹤0.01%	4247
2016 Q3	$925K	Buy	37,300 +18,700	+101%	+$497K	﹤0.01%	3937
2016 Q2	$462K	Sell	18,600 -2,500	-12%	-$64.4K	﹤0.01%	4595
2016 Q1	$610K	Buy	21,100 +11,800	+127%	+$308K	﹤0.01%	4126
2015 Q4	$280K	Sell	9,300 -3,200	-26%	-$109K	﹤0.01%	5320
2015 Q3	$372K	Buy	12,500 +3,300	+36%	+$107K	﹤0.01%	5245
2015 Q2	$322K	Sell	9,200 -8,300	-47%	-$293K	﹤0.01%	5652
2015 Q1	$621K	Buy	17,500 +2,300	+15%	+$77.5K	﹤0.01%	4599
2014 Q4	$527K	Sell	15,200 -8,100	-35%	-$286K	﹤0.01%	4662
2014 Q3	$823K	Buy	23,300 +19,700	+547%	+$743K	﹤0.01%	3960
2014 Q2	$145K	Sell	3,600 -8,100	-69%	-$311K	﹤0.01%	5899
2014 Q1	$467K	Buy	11,700 +200	+2%	+$7.2K	﹤0.01%	4436
2013 Q4	$380K	Sell	11,500 -12,800	-53%	-$399K	﹤0.01%	4336
2013 Q3	$713K	Buy	24,300 +5,400	+29%	+$169K	﹤0.01%	3439
2013 Q2	$637K	Buy	+18,900	New	+$585K	﹤0.01%	3611

Other funds holding DBD

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $25.5B AUM 28.85% 1-Year Est. Return

BFIM

Beese Fulmer Investment Management Canton, Ohio $1.56B AUM 26.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Citadel Advisors's DBD Position: Q2 2023 in Review

Citadel Advisors sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 180,265 shares — an estimated $216K sold.

Citadel Advisors first reported a position in DBD in Q2 2013 and held it in 37 quarters. The position peaked at $20.6M in Q4 2013. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

Citadel Advisors reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 180,265 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $216K.
Citadel Advisors first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 37 quarters.
Citadel Advisors's Diebold Nixdorf Incorporated position peaked at $20.6M in Q4 2013.
7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.